Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Isabel Ferrer Pérez

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 5, 2010
Dramatic complete response in patient with lung adenocarcinomaSara Serrano Solares, Dolores Isla Casado, María Jesús Vidal Losada, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 23, 2008
Skull base chondrosarcoma: a case treated by the CyberKnife systemAna Isabel Ferrer Pérez, Julio Lambea Sorrosal, María Jesús Vidal Losada, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 21, 2024
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer groupManuel Sánchez Cánovas, Miguel Ángel Moya Hernández, Evdochia Adoamnei, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 7, 2025
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer groupManuel Sánchez Cánovas, Javier López Robles, Francisco José García Verdejo, et al.
European Journal of Internal Medicine|August 5, 2022
Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basisSilvia García Adrián, Adán Rodríguez González, Eva Martínez de Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 10, 2023
Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer groupManuel Sánchez Cánovas, David Fernández Garay, Evdochia Adoamnei, et al.
BMC Cancer|November 18, 2025
Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial designMercedes Salgado, Juan de la Camara-Gómez, Ignacio García-Escobar, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 5, 2010
Dramatic complete response in patient with lung adenocarcinomaSara Serrano Solares, Dolores Isla Casado, María Jesús Vidal Losada, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 23, 2008
Skull base chondrosarcoma: a case treated by the CyberKnife systemAna Isabel Ferrer Pérez, Julio Lambea Sorrosal, María Jesús Vidal Losada, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 21, 2024
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer groupManuel Sánchez Cánovas, Miguel Ángel Moya Hernández, Evdochia Adoamnei, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 7, 2025
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer groupManuel Sánchez Cánovas, Javier López Robles, Francisco José García Verdejo, et al.
European Journal of Internal Medicine|August 5, 2022
Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basisSilvia García Adrián, Adán Rodríguez González, Eva Martínez de Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 10, 2023
Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer groupManuel Sánchez Cánovas, David Fernández Garay, Evdochia Adoamnei, et al.
BMC Cancer|November 18, 2025
Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial designMercedes Salgado, Juan de la Camara-Gómez, Ignacio García-Escobar, et al.
Pageof 1